Palvella Therapeutics, Inc.

Frazier Life Sciences Management, L.P. PVLA

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

722,400

Value ($000)

75,614

Weight

2.0%

2024 Q4 - 2025 Q4 (5 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	75,614	2.0%	722,400	12/31/2025
2025 Q3	11/14/2025	45,287	1.4%	722,400	9/30/2025
2025 Q2	8/14/2025	16,283	0.7%	722,400	6/30/2025
2025 Q1	5/15/2025	19,313	0.9%	690,012	3/31/2025
2024 Q4	2/18/2025	7,847	0.3%	653,892	12/31/2024